You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Liposarcoma

Showing 1 - 25 of 276
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dedifferentiated Liposarcoma Patients in China

Not yet recruiting
  • Dedifferentiated Liposarcoma
    • Beijing, China
      Beijing Jishuitan hospital
    Oct 30, 2023

    Engagement Patterns and Participation Trends Among Liposarcoma

    Not yet recruiting
    • Liposarcoma
      • San Francisco, California
        Power Life Sciences
      Sep 8, 2023

      Liposarcoma, Dedifferentiated Trial (Brigimadlin)

      Not yet recruiting
      • Liposarcoma, Dedifferentiated
      • (no location specified)
      Sep 22, 2023

      Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma

      Not yet recruiting
      • Advanced Dedifferentiated Liposarcoma
      • +5 more
      • (no location specified)
      Jan 11, 2023

      Dedifferentiated Liposarcoma, Soft Tissue Sarcoma, Sarcoma,Soft Tissue Trial in United States (Etrumadenant, Zimberelimab)

      Recruiting
      • Dedifferentiated Liposarcoma
      • +6 more
      • Basking Ridge, New Jersey
      • +6 more
      May 23, 2023

      Liposarcoma, Metastatic Liposarcoma Trial in Boston, Saint Louis, New York (MGCD516)

      Active, not recruiting
      • Liposarcoma
      • Metastatic Liposarcoma
      • Boston, Massachusetts
      • +2 more
      Nov 23, 2022

      Leiomyosarcoma, Liposarcoma Trial in New York (ATX-101)

      Recruiting
      • Leiomyosarcoma
      • Liposarcoma
      • New York, New York
        Columbia University Irving Medical Center / NewYork-Presbyterian
      Nov 23, 2022

      Tumors Trial in United States (letetresgene autoleucel (GSK3377794), Cyclophosphamide, Fludarabine)

      Completed
      Has Results
      • Neoplasms
      • letetresgene autoleucel (GSK3377794)
      • +2 more
      • Tampa, Florida
      • +5 more
      Oct 31, 2022

      Sarcoma, Dedifferentiated Liposarcoma Trial in New York (Abemaciclib)

      Active, not recruiting
      • Sarcoma
      • Dedifferentiated Liposarcoma
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Aug 17, 2022

      Status of Surgical Resection and Histologic Subtype as

      Completed
      • Liposarcoma of Soft Tissue
      • Surgical Procedure, Unspecified
      • Retroperitoneal Liposarcoma resection
      • São Paulo, Brazil
        Hospital das Clínicas da Faculdade de Medicina da Universidade d
      Jun 18, 2022

      Dedifferentiated Liposarcoma Trial in Beijing, Shanghai (TQB3616 capsule, TQB3616 )

      Not yet recruiting
      • Dedifferentiated Liposarcoma
      • TQB3616 capsule
      • TQB3616 placebo
      • Beijing, Beijing, China
      • +2 more
      Aug 9, 2022

      Tumors Trial in Worldwide (Letetresgene autoleucel)

      Active, not recruiting
      • Neoplasms
      • Letetresgene autoleucel
      • Pittsburgh, Pennsylvania
      • +5 more
      Aug 7, 2023

      Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

      Recruiting
      • Metastatic Leiomyosarcoma
      • +17 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Oct 13, 2022

      Liposarcoma, Malignant Abdominal Tumor, Malignant Retroperitoneal Tumor Trial in Portland (drug, radiation, other, procedure)

      Recruiting
      • Liposarcoma
      • +5 more
      • Eribulin Mesylate
      • +5 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Oct 17, 2022

      Advanced Dedifferentiated Liposarcoma Trial in United States (Abemaciclib, Placebo)

      Recruiting
      • Advanced Dedifferentiated Liposarcoma
      • Jacksonville, Florida
      • +6 more
      Jul 27, 2022

      Conventional Chondrosarcoma, Myxoid Liposarcoma, Mesenchymal Chondrosarcoma Trial in Netherlands, Spain (sirolimus and

      Completed
      • Conventional Chondrosarcoma
      • +3 more
      • sirolimus and cyclophosphamide
      • Leiden, Netherlands
      • +6 more
      Apr 19, 2022

      Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma Trial in France, Italy, Spain (Trabectedin, Radiotherapy)

      Recruiting
      • Liposarcoma, Myxoid
      • +4 more
      • Bordeaux, France
      • +15 more
      Jun 6, 2022

      Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

      Terminated
      • Neoplasms
      • New Haven, Connecticut
      • +20 more
      Jul 5, 2023

      Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

      Terminated
      • Neoplasms
      • New Haven, Connecticut
      • +20 more
      Sep 15, 2023

      Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma Trial in

      Active, not recruiting
      • Dedifferentiated Liposarcoma
      • +5 more
      • Ipilimumab
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 25, 2022

      Hepatocellular Carcinoma, Squamous Cell Carcinoma of the Lung, Merkel Cell Carcinoma Trial in Houston, Milwaukee (CAR-GPC3 T

      Recruiting
      • Hepatocellular Carcinoma
      • +3 more
      • CAR-GPC3 T Cells
      • Dallas, Texas
      • +2 more
      Dec 20, 2022

      Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)

      Active, not recruiting
      • Leiomyosarcoma
      • +3 more
      • Taipei, Taiwan
      • +1 more
      Dec 27, 2022

      Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

      Not yet recruiting
      • Breast Cancer
      • +5 more
      • (no location specified)
      Jun 7, 2023

      Liposarcoma, Dedifferentiated Trial in New York (SPH4336)

      Not yet recruiting
      • Liposarcoma, Dedifferentiated
      • New York, New York
        Columbia University Medical Center
      Oct 13, 2022

      Synovial Sarcoma, Myxoid Liposarcoma Trial in Worldwide (afamitresgene autoleucel (previously ADP-A2M4))

      Recruiting
      • Synovial Sarcoma
      • Myxoid Liposarcoma
      • afamitresgene autoleucel (previously ADP-A2M4)
      • Duarte, California
      • +26 more
      Dec 7, 2022